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SUMMARY                                                                                                              
Background: This study describes the burden of bleed-
ing oesophageal varices at the main tertiary referral 
centre in Accra.  
Design: Retrospective design to describe the endoscop-
ic spectrum and review mortality data following acute 
upper gastro-intestinal bleeding at the Korle-Bu Teach-
ing Hospital. Endoscopic data was reviewed in the En-
doscopy Unit between 2007 and 2010. Mortality data 
was collated from the Department of Medicine between 
2010 and 2013.  
Interventions: The study questionnaire compiled clin-
ical and demographic characteristics, endoscopic diag-
noses, length of hospital admission and treatment reg-
imens.  
Main outcome measures: Aetiology and time-trend 
analysis of mortality rates following acute upper gas-
tro-intestinal bleeding; variceal bleeding treatment mo-
dalities.  
Results: On review of the endoscopic diagnoses, gas-
tro-oesophageal varices were identified in 21.9% of 
cases followed by gastritis 21.7%, duodenal ulcer, 
17.0%, and gastric ulcer, 13.2%. Gastro-oesophageal 
varices were the predominant cause of death from 
acute upper gastro-intestinal haemorrhage from 46% in 
2010 to 76% in 2013. Outcomes following acute upper 
gastro-intestinal bleeding were dismal with some 38% 
of fatalities occurring within the first 24 hours. Injec-
tion sclerotherapy was the dominant endoscopic mo-
dality for secondary prevention of variceal bleeding in 
comparison with band ligation, mainly as a result of 
cost and availability. 
Conclusions: At the tertiary centre in Accra, variceal 
bleeding is an increasingly common cause of acute 
upper gastro-intestinal haemorrhage in comparison 
with previous reviews in Ghana. Its significantly high 
in-hospital mortality reflects inadequate facilities to 
deal with this medical emergency. A strategic approach 
to care with endoscopic services equipped with all the 
necessary therapeutic interventions will be vital in im-
proving the outcomes of variceal bleeding in Ghana.    
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INTRODUCTION 
Acute upper gastro-intestinal bleeding (AUGIB) is 
defined as bleeding that results from lesions located 
above the ligament of Treitz, a thin suspensory muscle 
attached to the duodenum.1 It is a common reason for 
emergency referral to hospital in patients with gastro-
intestinal disease.1 
 
AUGIB can be either variceal or non-variceal.2 Sources 
of non-variceal bleeding include peptic ulcer disease 
(PUD), oesophagitis, Mallory-Weiss tear, vascular 
anomalies, gastric and oesophageal malignancy.3 Gas-
tro-oesophageal varices (GOV) are dilated tortuous 
anastomotic veins prominent at the lower oesophagus 
and gastro-esophageal junction and are the most clini-
cally relevant porto-systemic collaterals in cirrhosis 
and portal hypertension.4 
 
They develop from connections between the short gas-
tric and coronary veins and the oesophageal, azygous 
and intercostals veins5. Varices will be present in 40% 
of patients with clinically compensated cirrhotic liver 
disease 2. This increases to 60% when decompensated 
with 90% developing oesophageal varices during the 
course of the disease.4  
 
Variceal bleeding is a life threatening complication of 
portal hypertension6. It is a major cause of morbidity 
and death in patients living with liver cirrhosis7 and 
accounts for 70% of all AUGIB episodes in the context 
of portal hypertension5. The risk of bleeding increases 
with increasing pressure and size of the varices as well 
as decreasing thickness of the variceal wall reflected by 









Variceal haemorrhage carries a significant mortality of 
20 – 30 %, therefore the identification and prophylactic 
treatment of patients at risk for esophageal bleeding is 
mandatory.8   
 
This study describes the scope of the problem and the 
therapeutic options in Ghana, a country with a 
significant burden of liver cirrhosis.9 
 
METHODS 
This study utilized a retrospective design to describe 
the endoscopic spectrum of disease following upper 
gastro-intestinal (GI) endoscopy for AUGIB at the En-
doscopy Unit, Korle-Bu Teaching Hospital (KBTH) 
between June, 2007 and August 2010. Additionally, it 
reviewed mortality data from AUGIB in the Depart-
ment of Medicine, KBTH from January, 2010 to No-
vember 2013.  
 
These time periods were studied because endoscopy 
and mortality data were consistently archived and 
available for analysis. The study was conducted be-
tween September 2012 and December 2013. Korle-Bu 
Teaching Hospital (KBTH) is the premier Teaching 
Hospital in the capital city of Ghana, Accra, with an 
estimated population of 3.9 million people. It is the 
main tertiary referral centre in Accra serving the major-
ity of the southern half of Ghana.  
 
The hospital has a total bed capacity of one thousand 
six hundred (1600) with a daily out-patient department 
(OPD) attendance of about one-thousand-two-hundred 
(1200) and an annual turnover of about three hundred 
and fifty thousand (350,000) patients.  The Endoscopy 
Unit runs two four-hour sessions per day on four days 
of the week. Approximately five patients attend each 
endoscopy session for upper-GI endoscopy.  
 
Mortality data in the Department of Medicine, KBTH, 
was derived from monthly departmental records while 
endoscopic data was captured from the Endoscopy Unit 
Log-book. Departmental mortality records review cap-
tured demographic data, duration of illness, symptoms 
and subsequent diagnosis.  
 
Endoscopically confirmed diagnoses of all mortality 
cases following AUGIB were recorded in this review. 
Where there was no prior documentation of endoscopic 
diagnosis, the aetiology was indicated as undeter-
mined. Consenting patients with GOVs undergoing 
injection sclerotherapy during the study period were 
administered a structured questionnaire.  
 
It included the sclerosant used, attendant complications 
such as pain, bleeding, dysphagia and endoscopic stric-
ture formation. Data were analyzed using Microsoft 
Excel and SPSS 16. Categorical data were expressed as 
proportions and presented in tables and bar charts.   
 
RESULTS 
Six-hundred and ninety-five (695) cases of AUGIB 
were investigated at the Endoscopy Unit, KBTH be-
tween 2007 and 2010 presenting as haematemesis 
and/or melaena. Table 1 demonstrates the endoscopic 
diagnoses following upper GI endoscopy. On review of 
the common pathologies encountered, GOVs were 
identified in 21.9% of cases followed by gastritis 
21.7%, duodenal ulcer (DU) 17.0%, and gastric ulcer 
(GU) 13.2%.   
 
Table 1 the aetiology of upper-GI haemorrhage follow-
ing endoscopy at the Korle-Bu   Teaching Hospital: 
2007 – 2010, (n:  695) 
Endoscopic diagnosis N % 
Gastro-esophageal varices 144 20.7 
Intra-gastric varices 8 1.2 
Esophagitis 41 5.9 
Duodenal ulcer 118 17.0 
Gastric ulcer 92 13.2 
Gastric erosion 27 3.9 
Gastritis 151 21.7 
Gastric cancer 40 5.8 
Normal  139 20.0 
 
Table 2 shows the mortality patterns following AUGIB 
at the KBTH’s Department of Medicine. One-hundred 
and ninety-six (196) mortality cases from AUGIB were 
recorded between 2010 and 2013 of which 70.1% were 
male and 29.1% female. AUGIB represented 3.8% 
(n=37) of all-cause mortalities in 2010, 4.3% (n=44), 
2011; 6.7% (n=66), 2012 and 5.8% (n=52), 2013 re-
spectively.  
 
Table 2 Mortality data on acute upper GI haemorrhage 
in the Department of Medicine, KBTH 
 2010 2011 2012 2013 
Total Admissions 6735 6801 7501 7114 
Total all-cause mortality cases  966 1014 981 890 
Total deaths from AUGIB: (n) 
- Deaths from variceal bleed-
ing  
- Deaths from bleeding PUD 
(DU+GU) 
- Deaths from AUGIB (unde-






















Figure 1 illustrates the age distribution of mortality 
cases from AUGIB with the commonest age group 
being 31 – 40 years, (24.5%) and 41 – 50 years, (25%). 
Bleeding GOVs were the predominant cause of death 
from AUGIB ranging from 45.9% (n=17) in 2010 to 
76.9% (n=40) in 2013. In 2013, the GOV: PUD mortal-










Figure 1 The Age distribution of patients with Upper 
GI Bleeding 
 
Figure 2 shows mortalities following AUGIB in rela-
tion to duration of hospital stay. Outcomes following 
AUGIB were dismal with some 38% (n=75) of fatali-
ties occurring within the first 24 hours and a further 
16.3% (n=32) in the subsequent 24 hours.  
 
Figure 2 Duration of hospital stay and Mortality fol-
lowing Acute Upper GI Bleeding 
 
A cross-sectional review of endo-therapy for GOVs at 
the Endoscopy Unit, KBTH, demonstrated that the 
mainstay of treatment was injection-sclerotherapy, per-
formed in 59 patients during the study period. Howev-
er, variceal rubber-band ligation therapy was also used 
when available.  
The sclerosant used was 5% ethanolamine oleate with 
2-3 (2.5ml) peri-variceal injections per sclerotherapy 
cycle.  
 
All patients had large GOVs, North Italian Endoscopic 
Classification (NIEC) (10), with multiple columns of 
distended varices. Thirty-two percent (32%, n=19) of 
patients had dysphagia following injection sclerothera-
py with a mean duration of 5.73 days; however no oe-
sophageal strictures were recorded following endosco-
py. Fifty-nine percent (59%, n=35) of patients had ex-
perienced post-procedure pain in the chest or abdomen 
which required either antacids or oral analgesia with 
paracetamol or tramadol.   
 
DISCUSSION 
Bleeding from the upper gastrointestinal tract is 
associated with significant morbidity and mortality. In 
the UK it accounts for 8% of emergency hospital 
admissions11 with an incidence of 47 – 116 / 100,000 
populations.12 The aetiology of AUGIB and 
relationship with mortality varies across populations. A 
UK population-based multi-centre, prospective survey 
reviewed over 4,000 cases of AUGIB across 74 
hospitals showing prevalence for GOVs, DU and GU 
as 4%, 18.6% and 12.3% respectively.13  
 
Mortality was however inversely related to prevalence; 
(23%) in variceal and (12%) in peptic ulcer disease 
patients13. By contrast, in our study, GOVs were 
identified in 22% of cases in comparison to DU, 
17.0%; and GU, 13.2%. It was second to peptic ulcer 
disease, which had an overall prevalence of 30.2% 
(DU+GU). This pattern was also demonstrated in a 
review of the clinical epidemiology of AUGIB in 
KBTH where there was a significant prevalence of 
bleeding GOVs amounting to 30%, almost equal to that 
for DU and GU cases which was 39.1%.14 Gastro-
oesophageal varices also remained the dominant cause 
of death from AUGIB ranging from 46% in 2010 to 
76% in 2013 in our review. Similarly, a review at the 
Kenyatta National Hospital15 demonstrated that GOVs 
were the commonest cause of AUGIB and were also 
responsible for the majority of its case fatalities. 
 
However, this trend in GOV prevalence has not always 
been evident in previous endoscopic series at KBTH. A 
review of upper-GI endoscopies for AUGIB between 
1981-1983 assessed 86 such patients with prevalence 
rates of GOV, 4.7%; DU, 31.4%; and GU, 8.1%16. In 
1982, Helicobacter pylori were discovered 17 and the 
1980s saw the advent of proton-pump inhibitors (PPI) 








It is likely that the relative increase in GOVs and con-
comitant reduction in prevalence of DU and GU may 
reflect the significant rise in PPI use and H. pylori ther-
apy in dyspeptic patients prior to endoscopy. A pattern 
therefore emerges which shows that variceal bleeding 
is a much more common cause of AUGIB in Ghana 
and Sub-Saharan Africa in comparison with developed 
countries. However, its attendant mortality remains 
high irrespective of geographic location. 
 
What seems alarming in our study is the high case fa-
tality in the first 24 hours of emergency admission in 
patients with AUGIB (38%). Difficulties faced in re-
suscitation, availability of appropriate facilities such as 
Seng-staken Blakemore tubes, access to therapeutic 
endoscopy and delayed referral are likely reasons in the 
face of such a burden of disease at the Tertiary Centre.  
 
Majority of sufferers were unfortunately relatively 
young, within the 30-50 year group, who are usually 
the backbone of the workforce and families in society. 
On the contrary, a similar sample population of patients 
with AUGIB in the UK was rather elderly, with a mean 
age of 66 years.13 This may reflect the differing 
aetiologies geographically. In Ghana for instance there 
is a significant burden of Hepatitis B acquired 
predominantly in early life with a prevalence of 
approximately 12-15% 19 leading to cirrhotic liver 
disease and associated portal hypertension.20 Liver 
cirrhosis is the commonest liver disease causing death 
in Ghana.20 
 
Prevalence of Hepatitis B in patients with cirrhotic 
liver disease was found to be 42.9%.20 Local data on 
other causes of liver injury such as alcohol and 
potentially hepatotoxic herbal medications are however 
lacking. In Europe, however, elderly patients tend to be 
more vulnerable to AUGIB particularly from peptic 
disease as a result of the higher incidence of multiple 
co-morbid conditions and use of non-steroidal anti-
inflammatory drugs (NSAIDs).2, 21, 22 
 
Injection sclerotherapy was the dominant endoscopic 
modality for secondary prevention of variceal bleeding 
in comparison with band ligation, mainly as a result of 
cost and availability. Over the study period, morbidity 
from the use of regular injection sclerotherapy was 
evident albeit temporary, with 32% of patients having 
reported dysphagia lasting approximately 5 days and 
some 60% experiencing post-procedure pain requiring 
analgesia. Both sclerotherapy and ligation can 
effectively arrest active bleeding from GOVs.23,24 
 
However, ligation is more-effective than sclerotherapy 
in decreasing the risk of re-bleeding from GOVs and 
can achieve variceal obliteration more rapidly with 
fewer complications such as ulceration, bleeding or 
oesophageal stricturing.23 In our study, the use of 
injection sclerotherapy was not associated with 
endoscopic stricture formation possibly as a result of 
the large varices encountered and therefore reduced 
para-variceal intimal injection and subsequent 
sclerosis.  
 
In Ghana, bleeding GOVs are a significant cause of 
AUGIB, identified in some 22% of patients with a 
comparatively high mortality. Cases demonstrated a 
male preponderance with in-hospital mortality (in 24 
hours) reflecting inadequate facilities to deal with this 
medical emergency. It is recommended that unstable 
patients are transfused with blood promptly, with plate-
lets if counts are below 50 X 109/ml and fresh frozen 
plasma if INR above 1.5.25 
 
Diagnostic and therapeutic endoscopy (e.g. band liga-
tion) is essential in all unstable patients after resuscita-
tion and to all other patients with AUGIB within 24 
hours.25 Octreotide or terlipressin in addition to 
prophylactic antibiotics with gram-negative cover also 
reduce morbidity and mortality in acute variceal bleed-
ing. 25, 26 
  
It is therefore hoped that an orchestrated and strategic 
approach to care with endoscopic services equipped 
with all the necessary therapeutic interventions will be 
vital in improving the outcomes of patients with vari-
ceal bleeding in Ghana. Further study evaluating the 
impact of other potential causes of cirrhotic liver dis-
ease would be important as it gains prominence in 
Ghana.    
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